Strides Pharma Science’s $24 Million Acquisition of Endo’s US Manufacturing Facility

Haynes and Boone represented Strides Pharma Science Limited in the transaction. Strides Pharma Science Limited announced that its wholly owned subsidiaries have entered into definitive agreements with...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here